Literature DB >> 7506186

Renal effects of nimesulide in furosemide-treated subjects.

F Steinhäuslin1, A Munafo, T Buclin, A Macciocchi, J Biollaz.   

Abstract

In clinical settings where effective plasma volume is decreased, nonsteroidal anti-inflammatory drugs (NSAIDs) may induce acute renal failure. We have evaluated the effects of single and repeated doses of nimesulide on renal haemodynamics and electrolyte excretion in 8 healthy volunteers during a prolonged course of furosemide (frusemide). Under these study conditions, renal prostaglandin synthesis is expected to be elevated, with renal function being dependent upon increased levels of prostaglandins. Nimesulide induced an acute but transient decrease in indices of renal haemodynamics. Furosemide-induced increases in plasma renin activity and aldosterone levels were blunted, and urinary excretion of prostaglandin E2 was markedly reduced by nimesulide. The magnitude and time course of the natriuretic, kaliuretic and diuretic effects of furosemide were attenuated by nimesulide. Although the transient nature of the observed renal haemodynamic changes suggests that the risk of developing acute renal failure is small, the rise should be taken into account in patients with renal dysfunction. Sodium and potassium retention, and the blunting of the diuretic-induced electrolyte excretion, could be of clinical relevance. Nimesulide appears, therefore, to share the prostaglandin-dependent renal effects of other NSAIDs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506186     DOI: 10.2165/00003495-199300461-00066

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  9 in total

Review 1.  Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)?

Authors:  K Brune
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Effects of nonsteroidal anti-inflammatory drugs in healthy subjects.

Authors:  J R Sedor; E W Davidson; M J Dunn
Journal:  Am J Med       Date:  1986-08-25       Impact factor: 4.965

Review 3.  Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs.

Authors:  D C Brater
Journal:  Am J Med       Date:  1986-01-17       Impact factor: 4.965

Review 4.  Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states.

Authors:  A Ward; R N Brogden
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

Review 5.  Renal syndromes associated with nonsteroidal antiinflammatory drugs.

Authors:  D M Clive; J S Stoff
Journal:  N Engl J Med       Date:  1984-03-01       Impact factor: 91.245

6.  Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods.

Authors:  J Nussberger; B Waeber; H R Brunner; J F Burris; W Vetter
Journal:  J Lab Clin Med       Date:  1984-11

7.  Natriuretic effect of furosemide after inhibition of prostaglandin synthetase.

Authors:  M D Bailie; K Crosslan; J B Hook
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

8.  Hyperkalemia associated with indomethacin.

Authors:  R C Goldszer; E L Coodley; M J Rosner; W M Simons; A B Schwartz
Journal:  Arch Intern Med       Date:  1981-05

9.  Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.

Authors:  J Nussberger; T Fasanella d'Amore; M Porchet; B Waeber; D B Brunner; H R Brunner; L Kler; A N Brown; R J Francis
Journal:  J Cardiovasc Pharmacol       Date:  1987-01       Impact factor: 3.105

  9 in total
  3 in total

Review 1.  Drug interactions with nimesulide.

Authors:  E Perucca
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of nimesulide.

Authors:  A Bernareggi
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

Review 3.  Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  R Davis; R N Brogden
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.